Antitrypsin Deficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Antitrypsin Deficiency stocks.

Antitrypsin Deficiency Stocks Recent News

Date Stock Title
Nov 21 BAX New Strong Sell Stocks for November 21st
Nov 19 BAX Baxter to Present at 7th Annual Evercore HealthCONx Conference
Nov 19 NTLA Intellia Therapeutics Announces Promising CRISPR Therapy Results
Nov 19 NTLA ReCode to secure funds for cystic fibrosis gene correction treatments
Nov 19 NTLA Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo
Nov 19 NTLA Intellia Therapeutics' Gene Therapies Fall Short Of Breakthroughs (Rating Downgrade)
Nov 18 ALNY Alnylam releases encouraging interim data on nucresiran for ATTR amyloidosis
Nov 18 NTLA Intellia’s gene editing therapy shows early potential in rare heart condition
Nov 18 ALNY ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
Nov 18 ALNY Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Nov 18 NTLA CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
Nov 17 INBX The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
Nov 17 ALNY Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
Nov 16 NTLA Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
Nov 16 BAX Baxter: Deleveraging At A Very Steep Price
Nov 15 INBX Inhibrx Biosciences GAAP EPS of -$2.84
Nov 14 INBX Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
Antitrypsin Deficiency

Antitrypsin Deficiency is a genetic disorder that affects the lungs and liver. It is caused by a deficiency of the protein alpha-1 antitrypsin (AAT), which is produced in the liver and helps protect the lungs from damage. People with Antitrypsin Deficiency are at an increased risk of developing lung diseases such as emphysema and chronic obstructive pulmonary disease (COPD). They may also be at risk of developing liver disease. Treatment for Antitrypsin Deficiency includes lifestyle changes, medications, and in some cases, a liver transplant.

Browse All Tags